Biohaven Ltd. BHVN

Set alert

14.48 USD +0.58 (+4.17%)

At closeNov 6, 2026, 6:40 PM EST

14.58 +0.10 +0.69%

After hours · Nov 6, 6:40 PM ET

13.76 Day range 14.50

7.48 52-week range 18.24

Held by insiders 11.20%

Held by institutions 96.18%

Float held by institutions 108.32%

Institutions 385

Top institutional holders
Holder	% held	Shares	Value	Reported
Blackrock Inc.	8.75%	13,210,585	191.03M	Jun 29, 2026
Montanova Capital LLC	6.81%	10,286,937	148.75M	Jun 29, 2026
Stifel Financial Corporation	6.58%	9,941,165	143.75M	Jun 29, 2026
Jupiter Topco LLC	5.68%	8,584,675	124.13M	Jun 29, 2026
Woodline Partners LP	5.07%	7,660,280	110.77M	Jun 29, 2026
State Street Corporation	4.60%	6,947,034	100.45M	Jun 29, 2026

Top mutual fund holders
Holder	% held	Shares	Value	Reported
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF	2.45%	3,699,312	53.49M	Sep 29, 2026
iShares Trust-iShares Russell 2000 ETF	2.29%	3,455,073	49.96M	Sep 29, 2026
Fidelity Select Portfolios-Select Biotechnology Portfolio	1.41%	2,130,196	30.80M	Sep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund	0.99%	1,489,215	21.53M	Jun 29, 2026
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund	0.97%	1,468,076	21.23M	Aug 30, 2026
iShares Trust-iShares Russell 2000 Growth ETF	0.83%	1,248,218	18.05M	Sep 29, 2026

BHVN insiders
Insider	Relation	Latest transaction	Date	Shares held
BAILEY GREGORY HUGH	Director	Purchase	Nov 12, 2025	2,020,070
BUTEN MATTHEW	Chief Financial Officer	Conversion of Exercise of derivative security	Jan 4, 2026	195,652
CAR BRUCE	Officer	Conversion of Exercise of derivative security	Jan 4, 2026	37,715
CHILDS JOHN W	Director	Purchase	Nov 12, 2025	0
CLARK GEORGE C.	Officer	Conversion of Exercise of derivative security	Jan 4, 2026	86,978
CORIC VLADIMIR	Chief Executive Officer	Conversion of Exercise of derivative security	Jan 4, 2026	3,849,350

Ownership